Andrés Vilella Weisz
Directeur/Membre du Conseil chez Alxerion Biotech Corp.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Javier Pedreno | M | - |
Alxerion Biotech Corp.
Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | 7 ans |
Elazer Edelman | M | 67 |
Alxerion Biotech Corp.
Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | - |
Ignacio Plaza | M | - |
Alxerion Biotech Corp.
Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | - |
Steven A. Hite | M | - |
Alxerion Biotech Corp.
Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 4 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Andrés Vilella Weisz
- Réseau Personnel